Editor's Note: The U.S. Food and Drug Administration on 2/22/08 approved the cancer drug Avastin for women with advanced breast cancer, going against the recommendation of its own advisory panel. Also see PJ's postscript at the end of this post for more details.
Avastin, a drug that’s shown great promise in slowing the progress of metastatic breast cancer, has been in the news again lately. No, not in the Journal of the American Medical Association. Nor even in American Cancer...


